Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

VersaCross Connect Access Solution for FARADRIVE (right) and VersaCross Connect LAAC Access Solution (left) product images

VersaCross Connect™ RF Transseptal Platform

Seamless integration, streamlined access

150,000+ patients treated with the VersaCross Connect RF Transseptal Platform*

The VersaCross Connect RF Transseptal Platform enables an integrated transseptal access workflow, leveraging zero exchange technology to enhance procedural efficiency. Designed for your FARAPULSE™ Pulsed Field Ablation (PFA) Platform and WATCHMAN™ Left Atrial Appendage Closure (LAAC) procedures, our reliable solutions seamlessly integrate into your workflows to help you achieve optimal patient outcomes.

Why choose VersaCross Connect transseptal access solutions?

Detail of assembly showing smooth transition between FARADRIVE Steerable Sheath and VersaCross Connect Transseptal Dilator, and WATCHMAN TruSteer Sheath and VersaCross Connect Transseptal Dilator.

Smooth dilator-to-sheath transition

Engineered for seamless integration with the FARADRIVE Steerable Sheath and WATCHMAN Access Sheath, the VersaCross Connect Transseptal Dilators enable smooth advancement into the left atrium (LA) with minimal dilator-to-sheath step-up.

Gloved hand holding VersaCross Connect Transseptal Dilator and shaping with TruForm shapeable technology.

TRUform™ technology

Reinforced with TRUform shapeable technology, the VersaCross Connect Transseptal Dilators deliver true-to-form curve retention to optimize trajectory to the fossa, and are designed to facilitate reshaping within your sheath to support precise positioning for various anatomies​.§,1

Hand in surgical glove bends the single, seamless transseptal dilator of the VersaCross Connect Access Solution for FARADRIVE.

Zero exchange therapy delivery

Instantly gain and maintain left heart access, securing your therapy sheath delivery with zero exchanges. The sturdy 3-in-1 VersaCross™ RF Wire, dedicated VersaCross Connect Transseptal Dilator, and your therapy sheath connect to streamline transseptal access, which may reduce the risk of exchange-related complications, such as silent cerebral events.1,2,3,4,5

The VersaCross Connect RF Transseptal Platform

Engineered for improved efficiency in your FARAPULSE PFA and WATCHMAN LAAC procedures

VersaCross Connect Access Solution for FARADRIVE

Streamline your FARAPULSE PFA workflow

The VersaCross Connect Access Solution for FARADRIVE delivers a simplified, integrated approach to left heart access, reducing procedural steps and eliminating the need for sheath exchanges compared to the VersaCross Access Solution fixed workflow. Designed for seamless compatibility in your FARAPULSE PFA procedures, VersaCross Connect enables predictable, zero exchange transseptal access by integrating with the FARADRIVE Steerable Sheath, helping to standardize your transseptal workflow while enhancing procedural confidence and consistency.

VersaCross Connect Access Solution for FARADRIVE workflow compared to VersaCross Access Solution workflow for FARAPULSE cases

Streamlined transseptal access workflow using VersaCross Connect Access Solution for FARADRIVE compared to the VersaCross Access Solution fixed workflow for FARAPULSE PFA Platform procedures.


VersaCross Connect LAAC Access Solution

Streamline your WATCHMAN LAAC workflow

The VersaCross Connect LAAC Access Solution provides an integrated, zero exchange workflow for left heart access in WATCHMAN LAAC procedures compared to the VersaCross Access Solution fixed workflow. The sleek design elimates the need for sheath exchanges by seamlessly integrating the VersaCross Connect Transseptal Dilator and WATCHMAN Access Sheath into a single, exchangeless system to reduce procedural steps. This optimized workflow promotes predictable access and enhanced efficiency, allowing you to focus on therapy sheath delivery with greater confidence and fewer steps.

VersaCross Connect LAAC Access Solution workflow for WATCHMAN cases

Streamlined transseptal access workflow using VersaCross Connect LAAC Access Solution compared to the VersaCross Access Solution fixed workflow for WATCHMAN LAAC procedures.

Publication highlights

VersaCross Connect Access Solution for FARADRIVE

March 2025, Osorio et al., published in Journal of Cardiovascular Electrophysiology

Early clinical experience with VersaCross Connect for left atrial access during pulsed field ablation procedures: findings from the DISRUPT-AF registry

VersaCross Connect Access Solution for FARADRIVE facilitated 100% transseptal crossing success in FARAPULSE Pulsed Field Ablation System procedures.


VersaCross Connect LAAC Access Solution

November 2022, Perrin et al., published in Catheterization and Cardiovascular Interventions

Procedural simplification of left atrial appendage occlusion using the VersaCross Connect system: First in-human experience

First in-human experience using the VersaCross Connect LAAC Access Solution for WATCHMAN FLX™ Left Atrial Appendage Closure Device implantation was successful in all patients with no procedural complications. VersaCross Connect improved procedural efficiency and saved six steps compared to the standard needle-based workflow.

Clinical experience

Hear from experts on their clinical experiences with the VersaCross Connect RF Transseptal Platform.

VersaCross Connect Access Solution for FARADRIVE

Suneet Mittal, MD shares his experience and workflow tailoring transseptal for FARAPULSE Pulsed Field Ablation Platform procedures with the VersaCross Connect Access Solution for FARADRIVE.


VersaCross Connect LAAC Access Solution

Devi Nair, MD, presents clinical data discussing her experience with the VersaCross Connect LAAC Access Solution for improved procedural efficiency and consistent deployment of WATCHMAN therapy devices, compared to needle-based workflows.

Reda Ibrahim, MD, highlights zero exchange transseptal technology for challenging LAAC cases, reflecting on the clinical advantages of VersaCross Connect LAAC Access Solution integration with WATCHMAN TruSteer™ Access Systems.

Ordering Information

VersaCross Connect Access Solution for FARADRIVE

1. Choose your VersaCross RF Wire

VersaCross RF Wire in j-tip and pigtail configurations.
VersaCross RF Wire                                                                                                                
RF wire length: 180 cm
Wire diameter: 0.035 in
Curve diameter: 9 mm (j-tip), 24 mm (pigtail)
2. Connect with VersaCross Connect Transseptal Dilator
VersaCross Connect Transseptal Dilator with TRUform shapeable technology
VersaCross Connect Transseptal Dilator with TRUform shapeable technology
Inner diameter: 0.035 in
Outer diameter: 13F
Usable length: 93 cm

VersaCross Connect LAAC Access Solution

1. Choose your VersaCross RF Wire                                                                                      
VersaCross RF Wire in j-tip and pigtail configurations.
VersaCross RF Wire                                                                                                                
RF wire length: 180 cm, 230 cm
Wire diameter: 0.035 in
Curve diameter: 9 mm (j-tip), 24 mm (pigtail)
2. Choose your VersaCross Connect Transseptal Dilator to complete your solution
VersaCross Connect Transseptal Dilator with TRUform shapeable technology
Inner diameter: 0.035 in
Outer diameter: 12F
Usable length: 85 cm

* 150,000+ patients treated with the VersaCross Connect RF Transseptal Platform inclusive of VersaCross Connect Access Solution for FARADRIVE and VersaCross Connect LAAC Access Solution, US lifetime sales. 

† The VersaCross Connect Transseptal Dilator is for use with a 13F (4.4 mm) ID FARADRIVE™ Steerable Sheath which is 74 cm in length, specifically, model: M004PF21M402 (US). 

‡ The VersaCross Connect Transseptal Dilator is for use with a 12F (4.2 mm) ID WATCHMAN Access Sheath that is 75 cm in length or the WATCHMAN TruSteer™ Access Sheath that is 67 cm in length, specifically: WATCHMAN Access System [Models: M635TU40060, M635TU10060, M635TU20060]; WATCHMAN TruSeal™ Access System [Models: M635TU70010, M635TU70040, M635TU70020]; WATCHMAN FXD Curve™ Access System [Models: M635TU80010, M635TU80020]; WATCHMAN TruSteer Access System [Model: M635TU90050].

§ Bench testing or pre-clinical study results may not necessarily be indicative of clinical performance. The testing was performed by or on behalf of Boston Scientific. Data on file.

References:

  1. Sayah N, Simon F, Garceau P, et al. Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair. Catheter Cardiovasc Interv. 2021;97(6):1230-1234. doi:10.1002/ccd.29365
  2. Dewland TA, Gerstenfeld EP, Moss JD, et al. Randomized Comparison of a Radiofrequency Wire Versus a Radiofrequency Needle System for Transseptal Puncture. JACC Clin Electrophysiol. 2023;9(5):611-619. doi:10.1016/j.jacep.2022.10.017
  3. Inohara T, Gilhofer T, Luong C, Tsang M, Saw J. VersaCross radiofrequency system reduces time to left atrial access versus conventional mechanical needle. J Interv Card Electrophysiol. 2022;63(1):9-12. doi:10.1007/s10840-020-00931-7
  4. Deneke T, Nentwich K, Schmitt R, et al. Exchanging Catheters Over a Single Transseptal Sheath During Left Atrial Ablation is Associated with a Higher Risk for Silent Cerebral Events. Indian Pacing Electrophysiol J. 2014;14(5):240-249. Published 2014 Oct 6. doi:10.1016/s0972-6292(16)30795-1
  5. Harada M, Motoike Y, Nomura Y, et al. Factors associated with silent cerebral events during atrial fibrillation ablation in patients on uninterrupted oral anticoagulation. J Cardiovasc Electrophysiol. 2020;31(11):2889-2897. doi:10.1111/jce.14716